This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Clostridium tetani
- DrugBank Accession Number
- DB09876
- Background
Not Available
- Type
- Biotech
- Groups
- Approved
- Biologic Classification
- Vaccines
Toxoid - Synonyms
- Bacillus tetani whole
- Clostridium tetani
- Clostridium tetani whole
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Boostrix Injektionssuspension in einer Fertigspritze Clostridium tetani (20 IU) + Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (8 μg) + Bordetella pertussis pertactin antigen (2.5 μg) + Corynebacterium diphtheriae (2 IU) + Pertussis vaccine (8 μg) Injection, suspension Intramuscular Glaxo Smith Kline Pharma Gmb H 2001-02-16 Not applicable Austria 
Boostrix Polio - Injektionssuspension in einer Fertigspritze Clostridium tetani (20 IU/0.5ml) + Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (8 mcg/0.5ml) + Bordetella pertussis pertactin antigen (2.5 mcg/0.5ml) + Corynebacterium diphtheriae (2 IU/0.5ml) + Pertussis vaccine (8 mcg/0.5ml) + Poliovirus type 1 antigen (formaldehyde inactivated) (40 [D'ag'U]/0.5ml) + Poliovirus type 2 antigen (formaldehyde inactivated) (8 [D'ag'U]/0.5ml) + Poliovirus type 3 antigen (formaldehyde inactivated) (32 [D'ag'U]/0.5ml) Injection, solution Intramuscular Glaxo Smith Kline Pharma Gmb H 2004-11-05 Not applicable Austria Td-pur für Erwachsene und Heranwachsende Clostridium tetani (20 IU) + Corynebacterium diphtheriae (2 IU) Injection, suspension Intramuscular Astro Pharma Vertrieb Und Handel Von Pharmazeutischen Produkten Gmb H 1999-03-22 Not applicable Austria Tetanus and Diphtheria Toxoids Adsorbed Clostridium tetani (2.0 1/0.5mL) + Corynebacterium diphtheriae (2.0 1/0.5mL) Injection Intramuscular Rebel Distributors 1967-10-13 Not applicable US 
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 751E8J54VM
- CAS number
- Not Available
References
- General References
- Not Available
- External Links
- Wikipedia
- Clostridium_tetani
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Completed Prevention Diphtheria / Pertussis / Tetanus 1 4 Completed Prevention Diphtheria / Tetanus 1 4 Unknown Status Prevention Pertussis 1 2 Completed Prevention Clostridium Difficile Immunisation / Diphtheria / Diphtheria Immunisation / Pertussis / Tetanus / Tetanus Immunisation 1 2 Completed Prevention Diphtheria / Pertussis / Poliomyelitis / Tetanus / Viral Hepatitis B 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Injection, suspension Intramuscular Injection, solution Intramuscular Injection Intramuscular - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at November 30, 2015 21:23 / Updated at June 12, 2020 16:52